Mitoxantrone
Links shared publicly online about this topic
Oncology Article | Leukemia Mitoxantrone Recurrence
mdlinx.com — “Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): An open-label randomised trial” View full resource at mdlinx.com
Most Recently Shared on December 9, 2010 at 7:47 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL... http://bit.ly/fZjxyo #oncology
Oncology Medical News about Mitoxantrone Lymphoma
mdlinx.com — “Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, recurrent/refractory follicular non-Hodgkin lymphoma with high tumor burden” View full resource at mdlinx.com
Most Recently Shared on June 28, 2010 at 8:50 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Efficacy and safety of the combination of rituximab, fludarabine, and mitoxantrone for rituximab-naive, r... http://bit.ly/awjKFV #oncology
Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis --" Neurology
neurology.org — “Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis --" Neurology” View full resource at neurology.org
Most Recently Shared on May 4, 2010 at 1:59 pm By:
Neurology Journal Medical Journal and Neurology
#AAN Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis http://bit.ly/bDtKDf
Child leukaemia survival boosted by mitoxantrone | News | Nursing Times
nursingtimes.net — “The survival rates of child leukaemia patients whose cancer has returned can be significantly improved with the chemotherapy drug mitoxantrone, a study has shown.” View full resource at nursingtimes.net
Most Recently Shared on December 7, 2010 at 7:24 am By:
News: Child leukaemia survival boosted by mitoxantrone http://bit.ly/glcaRM
Mitoxantrone increases survival for children with relapsed ALL, trial results show
news-medical.net — “A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia returns, according to the results of a trial published online in the Lancet today (Saturday).” View full resource at news-medical.net
Most Recently Shared on December 4, 2010 at 8:22 am By:
Mitoxantrone increases survival for children with relapsed ALL, trial results show: A new treatment increases su... http://bit.ly/fKaNfL
Mitoxantrone Is Significantly Better Than Idarubicin At Improving The Outcome Of Children With Relapsed Acute Lymphoblastic Leukaemia
medicalnewstoday.com — “Although survival in children with acute lymphoblastic leukaemia has improved dramatically in the past few decades, this has not been the case for those who relapse. In a trial that compared the c” View full resource at medicalnewstoday.com
Most Recently Shared on December 5, 2010 at 1:05 pm By:
MNT Pediatrics News Pediatrics and Health News
Mitoxantrone Is Significantly Better Than Idarubicin At Improving The Outcome Of Children With Relapsed Acute Lymphobl... http://mnt.to/3NwC
Infusional mitoxantrone plus bolus melphalan as a ... [Cancer Invest. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on February 18, 2011 at 11:53 pm By:
Robert Z. Orlowski Physician, Doctor, and Internist
Melphalan + mitoxantrone may be a good preparative regimen prior to stem cell transplantation (http://bit.ly/eOfIvq).
Rituximab + Vinorelbine, Ifosfamide, Mitoxantrone, and Prednisone: A Suitable Salvage Treatment for Patients With Relapsed Diffuse Large B-Cell Lymphoma - ONA
oncologynurseadvisor.com — “The combination of rituximab plus vinorelbine, ifosfamide, mitoxantrone, and prednisone (R-NIMP) is well tolerated, yields a high complete response rate, and allows for successful mobilization of CD34+ cells in patients with diffuse large B-cell lymphoma (DLBCL) in first relapse, results of a phase 2 study presented at the 52nd American Society of Hematology Annual Meeting and Exposition have found.” View full resource at oncologynurseadvisor.com
Most Recently Shared on December 6, 2010 at 4:05 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Rituximab + Vinorelbine, Ifosfamide, Mitoxantrone, and Prednisone: A Suitable Salvage… http://goo.gl/fb/YCMoS
Phase 1 and Pharmacokinetic Study of Bolus-Infusion Flavopiridol Followed by Cytosine Arabinoside and Mitoxantrone for Acute Leukemias - OncologySTAT
oncologystat.com — “Blood. 2011 Mar 24;117(12):3302-3310 - JE Karp, BD Smith, LS Resar, JM Greer, A Blackford, M Zhao, D Moton-Nelson, K Alino, MJ Levis, SD Gore, B Joseph, H Carraway, MA McDevitt, L Bagain, K Mackey, J Briel” View full resource at oncologystat.com
Most Recently Shared on April 7, 2011 at 4:12 pm By:
OncologySTAT Oncology and Health Site
Story of the Week With Expert Commentary: Hybrid FLAM Promising for Adult Leukemia http://tinyurl.com/3av8ydx
Multiple sclerosis drug linked to many more cases of leukemia - Multiple Sclerosis Blog
everydayhealth.com — “This morning at the American Academy of Neurology's conference in Seattle, a report was released reporting that there is a significantly increased risk of leukemia from the drug mitoxantrone (Novantrone) in patients with progressive forms of multiple sclerosis (MS)” View full resource at everydayhealth.com
Most Recently Shared on April 30, 2009 at 3:34 pm By:
MS drug linked to many more cases of leukemia http://tinyurl.com/d8f5ge
Leukemia Risk From MS Drug May Be Up - myOptumHealth
myoptumhealth.com — “Read the news article Leukemia Risk From MS Drug May Be Up at www.myOptumHealth.com” View full resource at myoptumhealth.com
Most Recently Shared on May 1, 2009 at 12:13 am By:
Leukemia Risk From MS Drug May Be Up: But few options require balancing dangers and benefits, experts say http://tinyurl.com/cbvql2
TheLancet.com
thelancet.com — “The Lancet is the world's leading general medical journal and specialty journals in Oncology, Neurology and Infectious Diseases. Available online first. Free registration.” View full resource at thelancet.com
Most Recently Shared on October 1, 2010 at 5:57 pm By:
NCI Cancer Bulletin Health News
Oct. 1 @TheLancet includes previously presented studies on rituximab in CLL, treating recurrent ovarian cancer: http://bit.ly/bG5Q1Q
Neurology Article | Multiple Sclerosis
mdlinx.com — “Mitoxantrone for worsening multiple sclerosis: Tolerability, toxicity, adherence and efficacy in the clinical setting” View full resource at mdlinx.com
Most Recently Shared on November 18, 2010 at 9:02 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Mitoxantrone for worsening multiple sclerosis: Tolerability, toxicity, adherence and efficacy in the clin... http://bit.ly/9H67tf #neuro
Oncology Medical News about Leukemia
mdlinx.com — “Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia” View full resource at mdlinx.com
Most Recently Shared on June 10, 2010 at 3:03 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newl... http://bit.ly/9YmCVW #oncology
Medical News: ASH: Regimen Ups Survival in Relapsed ALL in Kids - in Meeting Coverage, ASH: Hematology from MedPage Today
medpagetoday.com — “ORLANDO -- Children with relapsed acute lymphoblastic leukemia (ALL) had significantly better progression-free and overall survival when treated with induction therapy containing mitoxantrone versus t” View full resource at medpagetoday.com
Most Recently Shared on December 4, 2010 at 12:34 am By:
ASH: Regimen Ups Survival in Relapsed ALL in Kids (CME/CE) http://bit.ly/gJIqds
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Neurology Journal
Advertisement
